4 / 16
Page 54
Notes:
allied
academies
17
th
International Conference on
4
th
International Conference on
NEUROLOGY AND NEUROSCIENCE
&
MENTAL HEALTH AND PRIMARY CARE
October 16-18, 2017 | Toronto, Canada
J Neurol Neurorehabil Res 2017 | Volume 2 Issue 3
I
assume that serum concentration of total CoQ
10
and stress
oxidative factors could be used as important biomarkers
of therapy. One hundred and eighty children (aged 3-12
years), one group consisted of children with autism (n=90)
and other consisted of health children (n=90). Children with
autism according to the DSM-IV criteria and using CARS
were included in the study. All the subjects were Iranian,
born and living in the state Khuzestan. This was an original
study. The present study aimed to analyze the serum levels
of concentration of CoQ
10
−TOTAL, in the children. In total,
patient group and health group, including boys and girls,
were matched for age, gender, and body mass index (BMI).
Serum levels of CoQ
10
−TOTAL in children with ASDs were
significantly lower than that in the healthy children. We
propose that serum concentration of CoQ
10
−TOTAL could be
used as relevant biomarkers of CoQ
10
supportive therapy.
Overall supplementation with Co-Q
10
provides promising
alternatives to current therapies for neurodevelopmental
disorders. CoQ
10
is a naturally occurring flavonoidwith potent
antioxidant, properties that are found in green plants. This
study with a larger number of patients is confirmed these
previous research.
Speaker Biography
Elham Mousavinejad has completed her MSc in the Department of Biochemistry,
School of Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, in 2016,
and BSc Degree in Community Nutrition, School of Nutritional Sciences and Dietetics,
Jundishapur University of Medical Sciences, Ahvaz, Iran in 2006. Her research area
involved Nutritional Neuroscience and various nutritional deficiencies described in
children with ASDs.
e:
mousavinejad.e@ajums.ac.irCoenzyme-Q10 deficiency and stress oxidative in children with autism spectrum diseases
Elham Mousavinejad
University of Medical Sciences, Iran